Jorgensen Nathan D.
SEC CIK 1842523 · EDGAR
BoughtSold
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-24 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | S - Sale | $3.77 | -4,668 | 151.4K | -3% | -$17.6K | |
| D | 2026-02-10 | 2026-02-06 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +32.2K | 156.1K | +26% | $0 |
| 2025-10-07 | 2025-10-03 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | S - Sale | $4.78 | -7,666 | 123.8K | -6% | -$36.6K | |
| D | 2025-02-24 | 2025-02-21 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +51.5K | 131.5K | +64% | $0 |
| 2024-10-02 | 2024-10-01 | VYGR | Voyager Therapeutics, Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 | |
| 2024-05-07 | 2024-05-06 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $1.75 | -834 | 189.4K | -0.4% | -$1,460 | |
| 2024-05-03 | 2024-05-01 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $1.77 | -917 | 190.2K | -0.5% | -$1,623 | |
| 2024-03-05 | 2024-03-01 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $2.27 | -6,310 | 191.2K | -3% | -$14.3K | |
| 2024-02-08 | 2024-02-06 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $2.32 | -985 | 197.5K | -0.5% | -$2,285 | |
| D | 2024-01-31 | 2024-01-29 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +50.0K | 198.4K | +34% | $0 |
| 2023-11-08 | 2023-11-06 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $1.82 | -834 | 145.6K | -0.6% | -$1,518 | |
| 2023-09-06 | 2023-09-01 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $2.67 | -6,310 | 146.5K | -4% | -$16.8K | |
| 2023-08-09 | 2023-08-07 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $2.67 | -834 | 152.8K | -0.5% | -$2,227 | |
| 2023-05-10 | 2023-05-08 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $4.14 | -834 | 153.6K | -0.5% | -$3,453 | |
| 2023-03-02 | 2023-03-01 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | F - Tax | $5.51 | -6,310 | 154.5K | -4% | -$34.8K | |
| D | 2023-02-08 | 2023-02-06 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +45.5K | 160.8K | +39% | $0 |
| D | 2022-09-06 | 2022-09-01 | VOR | Vor Biopharma Inc. | Jorgensen Nathan D. | CFO | A - Grant | $0.00 | +86.0K | 115.3K | +294% | $0 |
Purchase Sale Sale after option exercise All abbreviations